{"DataElement":{"publicId":"3089865","version":"1","preferredName":"Esophageal Tumor Clinical N Stage","preferredDefinition":"the clinical N (nodal) stage of an esophageal tumor, as defined by the AJCC Cancer Staging Manual, 7th Ed.","longName":"ESOPH_TUM_V7_C_N_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2443107","version":"1","preferredName":"Esophageal Tumor Clinical N Stage","preferredDefinition":"information related to clinical N stage of esophageal.","longName":"ESOPHAG_TUMOR_C_N_S","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2452342","version":"1","preferredName":"Esophageal Neoplasm","preferredDefinition":"Of or relating to the esophagus.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C37950:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal","conceptCode":"C37950","definition":"Of or relating to the esophagus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-61C0-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 6th Ed., 2002","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0A400EF7-3EBA-3538-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-01-16","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"9/24/18 tt received permission for ownership transfer from CTEP to NCI Standards/BC. Updated to use Property based on NCIt concept","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3089824","version":"1","preferredName":"American Joint Committee on Cancer V7 Esophageal Tumor Clinical N Stage","preferredDefinition":"the clinical N (nodal) stage of an esophageal tumor, as defined by the AJCC Cancer Staging Manual, 7th Ed.","longName":"ESOPH_TUM_V7_C_N_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3","valueDescription":"Regional lymph node metastases involving 7 or more nodes","ValueMeaning":{"publicId":"3089825","version":"1","preferredName":"Regional lymph node metastases involving 7 or more nodes","longName":"3089825","preferredDefinition":"Regional lymph node metastases involving 7 or more nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87081A39-D8D2-A8DE-E040-BB89AD43310A","latestVersionIndicator":"Yes","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87081A39-D8EB-A8DE-E040-BB89AD43310A","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"ONEDATA","dateModified":"2010-05-20","deletedIndicator":"No"},{"value":"N2","valueDescription":"Regional lymph node metastases involving 3 to 6 nodes","ValueMeaning":{"publicId":"3089826","version":"1","preferredName":"Regional lymph node metastases involving 3 to 6 nodes","longName":"3089826","preferredDefinition":"Regional lymph node metastases involving 3 to 6 nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87081A39-D8F5-A8DE-E040-BB89AD43310A","latestVersionIndicator":"Yes","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87081A39-D90E-A8DE-E040-BB89AD43310A","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"ONEDATA","dateModified":"2010-05-20","deletedIndicator":"No"},{"value":"N1","valueDescription":"Regional lymph node metastases involving 1 to 2 nodes","ValueMeaning":{"publicId":"3089827","version":"1","preferredName":"Regional lymph node metastases involving 1 to 2 nodes","longName":"3089827","preferredDefinition":"Regional lymph node metastases involving 1 to 2 nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87081A39-D918-A8DE-E040-BB89AD43310A","latestVersionIndicator":"Yes","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87081A39-D931-A8DE-E040-BB89AD43310A","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"ONEDATA","dateModified":"2010-05-20","deletedIndicator":"No"},{"value":"N0","valueDescription":"NO REGIONAL LYMPH NODE METASTASIS","ValueMeaning":{"publicId":"2559539","version":"1","preferredName":"NO REGIONAL LYMPH NODE METASTASIS","longName":"2559539","preferredDefinition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN0 TNM Finding v6 and v7","conceptCode":"C73347","definition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MAESKEB","dateModified":"2018-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87081A39-D93B-A8DE-E040-BB89AD43310A","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"ONEDATA","dateModified":"2010-05-20","deletedIndicator":"No"},{"value":"NX","valueDescription":"REGIONAL LYMPH NODES CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559962","version":"1","preferredName":"REGIONAL LYMPH NODES CANNOT BE ASSESSED","longName":"2559962","preferredDefinition":"Lung cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pNX TNM Finding v6 and v7","conceptCode":"C60972","definition":"Lung cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B747-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87081A39-D945-A8DE-E040-BB89AD43310A","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"ONEDATA","dateModified":"2010-05-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2971712","version":"1","preferredName":"American Joint Committee on Cancer Stage","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B52EFA1-BE7C-1294-E040-BB89AD4332F7","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"87081A39-D8BE-A8DE-E040-BB89AD43310A","latestVersionIndicator":"Yes","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171061","version":"1","longName":"RTOG-1010","context":"NRG"}]}],"AlternateNames":[{"name":"ESOPH_TUM_V7_C_N_ST","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Clinical N Stage","type":"Preferred Question Text","description":"Clinical N Stage","url":null,"context":"CTEP"}],"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8707F77F-1475-A692-E040-BB89AD436501","latestVersionIndicator":"Yes","beginDate":"2010-05-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-20","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}